HD Labs Retatrutide & Cagrilintide Combo

HD LABS CAGRILINTIDE + RETATRUTIDE COMBO

An advanced metabolic research combination bringing together two investigational compounds with complementary pathways.

Retatrutide is a triple-receptor agonist studied for its activity at the GLP-1, GIP and glucagon receptors, while Cagrilintide is a long-acting amylin analogue researched for its role in appetite, satiety and energy-balance signalling.

This combination is intended for research into:

• Appetite and satiety pathways
• Metabolic signalling
• Energy regulation
• Glucose and insulin pathways
• Body-composition research

For laboratory and research purposes only. Not intended for human or veterinary consumption. These compounds remain investigational and are not approved to diagnose, treat, cure or prevent any disease.